About General transcription factor IIE subunit 1
General transcription factor IIE subunit 1 (GTF2E1) is a protein
from Homo sapiens identified by UniProt accession
P29083, 439 residues long.
MolForge cross-references it against 0 known binders and
10 disease associations.
Target properties
| Protein name | General transcription factor IIE subunit 1 |
| UniProt accession | P29083 |
| Gene | GTF2E1 |
| Organism | Homo sapiens |
| Length | 439 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (10)
Diseases linked to this target (Open Targets).
- HIV infection · score 0.58
- neurodegenerative disease · score 0.53
- pancreatic adenocarcinoma · score 0.18
- preeclampsia · score 0.03
- hepatocellular carcinoma · score 0.00
- Systemic lupus erythematosus · score 0.00
- invasive breast ductal carcinoma · score 0.00
- cancer · score 0.00
- xeroderma pigmentosum · score 0.00
- retinal degeneration · score 0.00
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-P29083-F1 | alphafold | PREDICTED | 66.67 | — |
Amino-acid sequence (439 residues)
MADPDVLTEV PAALKRLAKY VIRGFYGIEH ALALDILIRN SCVKEEDMLE LLKFDRKQLR SVLNNLKGDK FIKCRMRVET AADGKTTRHN YYFINYRTLV NVVKYKLDHM RRRIETDERD STNRASFKCP VCSSTFTDLE ANQLFDPMTG TFRCTFCHTE VEEDESAMPK KDARTLLARF NEQIEPIYAL LRETEDVNLA YEILEPEPTE IPALKQSKDH AATTAGAASL AGGHHREAWA TKGPSYEDLY TQNVVINMDD QEDLHRASLE GKSAKERPIW LRESTVQGAY GSEDMKEGGI DMDAFQEREE GHAGPDDNEE VMRALLIHEK KTSSAMAGSV GAAAPVTAAN GSDSESETSE SDDDSPPRPA AVAVHKREED EEEDDEFEEV ADDPIVMVAG RPFSYSEVSQ RPELVAQMTP EEKEAYIAMG QRMFEDLFE
Explore General transcription factor IIE subunit 1 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets